Mesenchymal Stem Cells Market Size

Mesenchymal Stem Cells Market size was over USD 3.93 billion in 2024 and is anticipated to cross USD 22.59 billion by 2037, witnessing more than 14.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of mesenchymal stem cells is estimated at USD 4.38 billion.

The growth of the market can be attributed to the growing demand for the treatment of various degenerative and rare diseases, including osteoporosis, cancer, spinal cord injuries, type 1 diabetes, Parkinson's disease, cartilage infection, and ischemic cardiac diseases. The growing prevalence of these ailments is anticipated to be the primary growth driver for the market. According to the data from the World Health Organization (WHO), in 2017 9 million people were suffering from type 1 diabetes. Moreover, a report by the Parkinson's Foundation revealed that around 10 million people worldwide are living with Parkinson’s disease, and 4% of the cases are diagnosed before the age of 50 years.

In addition to these factors, mesenchymal stem cells, or MSCs are extensively used as a regenerative treatment method, which is estimated to boost market growth over the forecast period. Regenerative treatment is used excessively in cardiovascular disease, type 1 diabetes, brain injury tissue repair, and others. Regenerative treatment is a method of using new treatment to cure tissues and organs to recover their function that is lost owing to certain diseases and aging. Furthermore, the growing awareness amongst people regarding early diagnosis and treatment of rare diseases, along with growing healthcare expenditure, is projected to influence market development.